Methodology Polymerase chain reaction (PCR) CPT Codes 87529 each type - Herpes simplex virus, amplified probe technique Specimen Requirements
- HSV lesion MPLN path. collection kit
- 2.0 mL whole blood EDTA
- 5 mm^3 fresh or frozen tissue
- Swab from any site MPLN pathogen collection kit or viral
transport media
- 2.0 mL (min. 1.0 mL) CSF sterile container, DO NOT DILUTE
- 2.0 mL (min. 1.0 mL) Cervical cells, ThinPrep® PAP solution or SurePath™ Test Pack solution
- 1.0 mL amniotic fluid, sterile container, unspun
Specimen Stability
- MPLN pathology collection kit, 18-25°C, ambient
- Whole blood, 4°C, stable 96 hours
- Fresh tissue, 4°C, stable 96 hours
- Frozen tissue, -20°C, freeze immediately
- Swab from any site, 4°C, stable 96 hours
- CSF, 4°C, stable 72 hours
- CSF, -20°C, freeze within 4 hours
- Cervical cells, 18-25°C, stable 21 days
- 1 mL amniotic fluid, 18-25°C, stable 48 hours
Storage & Handling
- MPLN pathology collection kit, ship ambient
- Whole blood, ship with ice pack. Separate ice pack from specimen
- Fresh Tissue, MPLN transport medium or equivalent (i.e. RPMI, Hanks, M4 media), ship with ice pack. Separate ice pack from specimen
- Frozen tissue, MPLN transport medium or equivalent (i.e. RPMI, Hanks, M4 media), ship with dry ice
- Swab from any site MPLN pathogen collection kit or viral
transport media, ship with ice pack. Separate from specimen
- CSF fresh, sterile container, do not dilute, ice pack Refrigerated CSF MUST be shipped within 24 hours of collection
- CSF frozen, sterile container, do not dilute, freeze within 4 hours, ship on dry ice
- Cervical cells, ThinPrep PAP solution or SurePath Test Pack solution, ship ambient
- Amniotic fluid, sterile container, unspun, ship ambient
Causes for Rejection Improper anticoagulant; Improper shipping media; Recommended temperatures exceeded; Age of specimen exceeded Reference Range Negative: HSV DNA not detected (< 10 copies/mL)
Positive: HSV DNA detected (>/= 10 copies/mL) Description Intended for use to assist in the confirmation of a diagnosis of a HSV-1 and/or HSV-2 infection. Trademarks ThinPrep is a registered trademark of Cytyc Corportation.
SurePath is a trademark of Becton, Dickinson and Company.
|
|